Physicians See New Benefits, Treatment Opportunities for Brain Cancer with Elekta's Leksell Gamma Knife Perfexion
ATLANTA, July 1 /PRNewswire/ -- The refinements in Elekta's Gamma Knife® surgery technology that created the fifth generation Leksell Gamma Knife® Perfexion™ are radically changing the approach to treating brain metastases and other brain disorders. With Perfexion, physicians are applying therapy to multiple metastases (mets) in a single session, treating more non-malignant targets located in critical areas and planning increasingly tailored plans to meet individual patient needs. The result has been an upsurge in Perfexion sales and upgrades from the previous model Leksell Gamma Knife® 4C in North America.
Elekta recently announced its fourth quarter orders for Leksell Gamma Knife Perfexion, including Methodist Hospital (San Antonio), Memorial Hermann-Texas Medical Center (Houston), New York-Presbyterian Hospital and Swedish Cancer Institute (Seattle).
"Since the introduction of Perfexion, 40 percent of Gamma Knife systems in North America are, or wi